
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading TechBio company in London is seeking a Head of Toxicology to oversee drug safety strategies and lead a skilled team. The role requires a Ph.D. and experience in drug discovery and development. The ideal candidate will ensure cutting-edge safety practices while collaborating closely with various teams. The position offers competitive compensation ranging from £134,200 to £172,100 and includes additional bonuses and equity options.
As the Head of Toxicology, you will sit at the crucial intersection of Discovery and Development, supporting both our internal pipeline and strategic partnerships. You will lead a team responsible for embedding modern, data-driven decision-making into our NCE progression, ultimately accelerating our mission to decode biology to radically improve lives.
As a forward-looking leader, you will be instrumental in positioning Recursion at the forefront of the industry's shift away from reliance on traditional pre-clinical studies. You will champion the adoption and validation of highly predictive human models, as this is central to our TechBio approach of industrializing drug discovery.
You will lead the Toxicology function and operate in a highly cross‑functional manner, collaborating closely with leaders across Discovery, Clinical Development, Translational Biology, and our core AI/ML and Data Science organizations across our various locations.
This is an office-based, hybrid position at one of our offices located in Salt Lake City, Utah / London / New York City. Employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is £134,200 to £172,100 (GBP). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.